Oliman, Zulma .

HRN: 21-46-28  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/12/2022
CEFTRIAXONE 1G (VIAL)
06/12/2022
06/18/2022
IV
1g
Od
Pcap C With HRAD
Waiting Final Action 
06/12/2022
CEFUROXIME 750MG (VIAL)
06/12/2022
06/18/2022
IV
335mg
Q8hrs
Pcap C With HRAd
Waiting Final Action 
06/13/2022
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
06/13/2022
06/18/2022
ORAL
2.5ml
OD
PCAP-C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: